America’s generic drug crisis demands investment, not dependence

America’s Generic Drug Crisis Demands Investment, Not Dependence

The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on foreign manufacturers for generic drugs is at the center of it.

CPA Applauds President Trump’s “Liberation Day” Tariff Announcement as Essential Reset of Global Trade System

CPA Applauds President Trump’s “Liberation Day” Tariff Announcement as Essential Reset of Global Trade System

The Trump administration’s decision to impose a permanent 10% baseline tariff on imports from all countries, combined strategically with higher reciprocal tariffs on nations engaging in unfair trade practices, marks a crucial step forward in reindustrializing America and restoring economic strength and security.

What the National Institutes of Health Does for the Economy and the Health of Our Citizens

What the National Institutes of Health Does for the Economy and the Health of Our Citizens

The National Institutes of Health (NIH) is today the main source of new drugs in this country – indeed the world, because America leads in the field. It has a critical importance to America’s health. Less well known is its huge, positive, economic impact.

CPA Strongly Supports Proposed USTR Actions Against Chinese Dominance in Maritime and Shipbuilding Sectors

CPA Strongly Supports Proposed USTR Actions Against Chinese Dominance in Maritime and Shipbuilding Sectors

In a comment letter submitted to USTR in response to the Section 301 investigation, CPA highlighted China’s extensive use of state-driven subsidies and unfair trade practices, urging immediate implementation of targeted measures to support the revitalization of the U.S. shipbuilding industry.